Buscar
01/11/2022
Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain
Castro, A, Diaz, P, Domingo, P, Garcia-Yubero, C, Losa-Garcia, JE, Castro, A, Vidal-Vilar, N, Aceituno, S. Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain. Farmacia Hospitalaria. 2022; 46(6)DOI:10.7399/fh.13038. PMID:36520571. IF:(Q/D).
01/11/2022
Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes
Domingo, P, Quesada-Lopez, T, Villarroya, J, Cairo, M, Gutierrez, MD, Mateo, MG, Mur, I, Corbacho, N, Domingo, JC, Villarroya, F, Giralt, M. Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes. LIFE SCIENCES. 2022; 308DOI:10.1016/j.lfs.2022.120948. PMID:36096241. IF:6.100(Q1/2D).
01/10/2022
The role of nurses in the prevention of anal cancer in HIV- infected men having sex with men - a focus on papillomavirus vaccination and anal cytology screening
Munoz-Rodriguez, J, Millan-Revilla, L. The role of nurses in the prevention of anal cancer in HIV- infected men having sex with men - a focus on papillomavirus vaccination and anal cytology screening. AIDS REVIEWS. 2022; 24(4)DOI:10.24875/AIDSRev.M22000053. PMID:36580603. IF:2.200(Q4/8D).
01/01/2022
Observational cohort study of rilpivirine (RPV) utilization in Europe
Cozzi-Lepri A., Peters L., Pelchen-Matthews A., Neesgaard B., Stephan C., Elbirt D., Brännström J., Paduta D., Trofimova T., Szlavik J., Van Eygen V., Pai H., Lundgren J., Harxhi A., Losso M., Kundro M., Schmied B., Karpov I., Vassilenko A., Paduto D., Mitsura V.M., Clumeck N., De Wit S., Delforge M., Hadziosmanovic V., Begovac J., Machala L., Jilich D., Gerstoft J., Pedersen C., Sedlacek D., Kronborg G., Benfield T., Johansen I.S., Ostergaard L., Wiese L., Moller N.F., Nielsen L.N., Zilmer K., Smidt J., Aho I., Viard J.P., Girard P.M., Pradier C., Fontas E., Duvivier C., Rockstroh J., Degen O., Hoffmann C., Stellbrink H.J., Stefan C., Bogner J., Fätkenheuer G., Chkhartishvili N., Sambatakou H., Adamis G., Paissios N., Uzdaviniene V., Staub T., Dragas S., Reiss P., Trajanovska J., Reikvam D.H., Maeland A., Bruun J., Knysz B., Szetela B., Inglot M., Bakowska E., Flisiak R., Grzeszczuk A., Parczewski M., Maciejewska K., Aksak-Was B., Beniowski M., Mularska E., Jablonowska E., Kamerys J., Wojcik K., Mozer-Lisewska I., Rozplochowski B., Zagalo A., Radoi R., Oprea C., Yakovlev A., Trofimora T., Khromova I., Kuzovatova E., Borodulina E., Vdoushkina E., Ranin J., Tomazic J., Miro J.M., Laguno M., Martinez E., Garcia F., Blanco J.L., Martinez-Rebollar M., Mallolas J., Callau P., Rojas J., Moreno S., del Campo S., Jou A., Paredes R., Puig J., Llibre J.M., Santos J.R., Domingo P., Gutierrez M., Mateo G.M., Sambeat A., Laporte J.M., Svedhem V., Thalme A., Sonnerborg A., Flamholc L., Kusejko K., Weber R., Calmy A., Furrer H., Battegay M., Schmid P., Kuznetsova A., Mikhalik J., Sluzhynska M., Milinkovic A., Johnson A.M., Simons E., Edwards S., Phillips A.M., Johnson A., Mocroft A., Orkin C., Winston A., Clarke A., Leen C.. Observational cohort study of rilpivirine (RPV) utilization in Europe. AIDS Research and Therapy. 2022; 19(1)DOI:10.1186/s12981-022-00457-0. PMID:35933352. IF:2.200(Q4/8D).
01/01/2022
Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study
Martin-Iguacel R., Reyes-Urueña J., Bruguera A., Aceitón J., Díaz Y., Moreno-Fornés S., Domingo P., Burgos-Cibrian J., Tiraboschi J.M., Johansen I.S., Álvarez H., Miró J.M., Casabona J., Llibre J.M.. Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study. Eclinicalmedicine. 2022; 52DOI:10.1016/j.eclinm.2022.101600. PMID:35958520. IF:15.100(Q1/1D).
01/01/2022
A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
Garreta E., Prado P., Stanifer M.L., Monteil V., Marco A., Ullate-Agote A., Moya-Rull D., Vilas-Zornoza A., Tarantino C., Romero J.P., Jonsson G., Oria R., Leopoldi A., Hagelkruys A., Gallo M., González F., Domingo-Pedrol P., Gavaldà A., del Pozo C.H., Hasan Ali O., Ventura-Aguiar P., Campistol J.M., Prosper F., Mirazimi A., Boulant S., Penninger J.M., Montserrat N.. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells. Cell Metabolism. 2022; 34(6)DOI:10.1016/j.cmet.2022.04.009. PMID:35561674. IF:29.000(Q1/1D).